search icon
  • Print
  • ShareThis
  • Text Size
  • View all Antimicrobial Resistance Content for Public Policy

  • Search More Public Policy

    IDSA Recommendations to United Nations on Antimicrobial Resistance (PDF)

    IDSA provided recommendations in advance of a United Nations (UN) High Level Meeting on Antimicrobial Resistance in September; IDSA recommends focus on surveillance data collection, antimicrobial stewardship, antimicrobial drug and diagnostic research and development, vaccination and infection prevention, and investment in an infectious diseases physician workforce.

    Patient Stories

    Many patients and their families have suffered the debilitating effects of drug-resistant infections.IDSA believes it is important to tell their stories to spur the development of new treatments and to strengthen efforts to control drug resistance. If you would like to share your story, please contact Jen Ford at

    IDSA Policy: Antimicrobial Resistance

    IDSA is working on several fronts to counter “bad bugs” including by promoting development of new drugs, eliminating inappropriate use of antibiotics in agriculture, promoting antimicrobial stewardship programs, and strengthening the U.S. response through surveillance, prevention and control, and research efforts.

    New Antibiotic Approval Pathway Would Address Critical Need (PDF)

    The Society’s proposed Limited Population Antibacterial Drug (LPAD) mechanism would streamline the development of antibiotics needed to treat the most serious infections.

    IDSA Statement at PCAST Public Meeting on Antibiotic Resistance (PDF)

    IDSA presented comments at the President's Council of Advisors on Science and Technology (PCAST) Public Meeting on Antibiotic Resistance.  IDSA is encouraged by the closer attention the federal government is paying to the public health crisis posed by antibiotic resistance, but the need for comprehensive, concrete actions is overdue.  (April 2014)

    Help Win Congress’s Support for New Antibiotics

    Legislative Action Alert: We need your help urging Congress to provide a new FDA approval pathway to help companies bring to market the most urgently needed new antibiotics. Contact Congress today and support the Antibiotic Development to Advance Patient Treatment (ADAPT) Act.

    Facts about Antibiotic Resistance

    The incidence of antibiotic-resistance has been rapidly increasing. At the same time, fewer new antibiotics are being developed.

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site